MONECO Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

MONECO Advisors’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,044	Closed	-$754K	–	512
2025 Q2	$754K	Hold	16,044	–	–	0.07%	227
2025 Q1	$708K	Sell	16,044 -1,808	-10%	-$83.2K	0.07%	223
2024 Q4	$645K	Hold	17,852	–	–	0.07%	238
2024 Q3	$572K	Hold	17,852	–	–	0.07%	233
2024 Q2	$672K	Hold	17,852	–	–	0.1%	194
2024 Q1	$879K	Hold	17,852	–	–	0.14%	166
2023 Q4	$652K	Hold	17,852	–	–	0.12%	183
2023 Q3	$413K	Hold	17,852	–	–	0.11%	209
2023 Q2	$468K	Hold	17,852	–	–	0.13%	182
2023 Q1	$460K	Hold	17,852	–	–	0.14%	173
2022 Q4	$464K	Hold	17,852	–	–	0.17%	140
2022 Q3	$509K	Hold	17,852	–	–	0.2%	116
2022 Q2	$440K	Buy	+17,852	New	+$653K	0.17%	134

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

MONECO Advisors's SWTX Position: Q3 2025 in Review

MONECO Advisors sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 16,044 shares — an estimated $754K sold.

MONECO Advisors first reported a position in SWTX in Q2 2022 and held it in 13 quarters. The position peaked at $879K in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

MONECO Advisors reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
MONECO Advisors sold 16,044 SpringWorks Therapeutics shares in Q3 2025, an estimated $754K.
MONECO Advisors first reported a position in SpringWorks Therapeutics in Q2 2022 and held it in 13 quarters.
MONECO Advisors's SpringWorks Therapeutics position peaked at $879K in Q1 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on MONECO Advisors's 13F filing for Q3 2025, filed 5 Nov 2025.